Vaccine Scheduler
Hepatitis A: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Months | Years | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 15-18 | 2 | 6 | 7 | 12 | 16 | 18 | 19 | ≥ 20 | ||
| Austria | |||||||||||
| Belgium | HepA1 | ||||||||||
| Bulgaria | HepA2 | ||||||||||
| Croatia | |||||||||||
| Cyprus | HepA3 | ||||||||||
| Czechia | HepA4 | ||||||||||
| Denmark | |||||||||||
| Estonia | |||||||||||
| Finland | HepA5 | ||||||||||
| France | |||||||||||
| Germany | |||||||||||
| Greece | HepA | HepA | HepA | ||||||||
| Hungary | |||||||||||
| Iceland | |||||||||||
| Ireland | |||||||||||
| Italy | HepA6 | HepA7 | |||||||||
| Latvia | |||||||||||
| Liechtenstein | |||||||||||
| Lithuania | |||||||||||
| Luxembourg | |||||||||||
| Malta | |||||||||||
| Netherlands | |||||||||||
| Norway | |||||||||||
| Poland | |||||||||||
| Portugal | HepA8 | ||||||||||
| Romania | |||||||||||
| Slovakia | HepA9 | HepA10 | |||||||||
| Slovenia | |||||||||||
| Spain | |||||||||||
| Sweden | |||||||||||
Footnotes:
- For specific risk groups (see detailed information https://www.health.belgium.be/fr/avis-8816-vaccination-de-ladulte-contre-lhepatite-b-fiche )
- Combined immunization against hepatitis A and B is indicated for all persons aged 16 and over who do not have immune protection against both diseases. It is recommended to administer it as early as possible, especially in people at risk of infection or severe disease. More information: https://plusmen.bg/bg/optional/hepatitis
- Two doses at 24 and 30 months of age.
- General recommendation for all population. 2 doses, if susceptible and no history of vaccination. Mandatory for specific at-risk groups. Vaccination not funded by the National Health system except at-risk groups.
- For risk-groups only.
- Recommended in highly endemic areas
- Recommended in highly endemic areas
- Vaccination of high-risk groups. More information available at: https://www.dgs.pt/ficheiros-de-upload-2013/27hepatite-a-ultima-atualizacao-23102025_vf-pdf.aspx
- HAV generally recommended to children with no legislative support. This period is an indication and subsequent doses can be administered differently, if the starting dose was administered differently than from the original recommended age.
- Free of charge for 2 year old children living in poor hygienic conditions or without access to clean drinking water.